跳至主要内容
临床试验/ACTRN12623001288617
ACTRN12623001288617尚未招募Unknown

Clinical trial investigating the efficacy and safety of insulin delivery with a prototype ultra-low-cost insulin pump in adults with type 1 diabetes

niversity of Canterbury0 个研究点目标入组 6 人开始时间: 2023年12月11日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Type 1 diabetes as classified by the American Diabetes Association
  • 2. Aged 18 years or older
  • 3. Currently using insulin pump therapy for management of diabetes
  • 4. Currently receiving basal insulin at a rate compatible with the investigational ultra-low-cost insulin pump
  • 5. HbA1c < 97 mmol/mol (11.0%), based on the mean of all HbA1c results within the 6 months prior to the screening visit, or HbA1c at screening if no results are available
  • within the prior 6 months.
  • 6. Willing and able to adhere to the study protocol

排除标准

  • 1. A positive pregnancy test at screening is exclusionary
  • 2. If female, is currently breastfeeding
  • 3. Severe hypoglycaemia or diabetic ketoacidosis in the 6 months prior to study commencement.
  • 4. Allergic or intolerant to Humalog® and NovoRapid® insulin
  • 5. Alcohol or drug dependence (as reported by participants)
  • 6. Any comorbid medical or psychological factors that would, on assessment by the investigators, make the person unsuitable for the study
  • 7. A lack of English literacy that would, on assessment by the investigators, make the person unsuitable for the study

研究者

发起方
niversity of Canterbury

相似试验

Investigating the efficacy and safety of a prototype... | 临床试验